I've seen articles saying that it would be hard to find any large enough investors to buy it who also don't cause a monopoly. Can ByteDance spin off TikTok to a separate company which would have an IPO and go public and in the process no longer have Chinese owners?
Anthropic's Claude summarized this, too (the article was too long for ChatGPT):
In April 1993, Don Calhoun made a miraculous full-court shot during a Chicago Bulls game to win $1 million. He was an average office supply salesman but felt calm and destined to make the nearly impossible shot.
The shot went viral and sparked a boom in in-game contests at sporting events. Companies like SCA Promotions started insuring these big-money contests, which remained popular crowd pleasers.
Calhoun initially feared he wouldn't get the money because he had played some college basketball recently. This violated a common rule that contestants couldn't have played the sport recently.
The Bulls held a press conference saying they would pay Calhoun the $1 million regardless of the insurance outcome. Later, Michael Jordan privately told Calhoun that the Bulls players had pressured the insurance company to pay him.
Calhoun got Jordan to sign the winning ball years later after persistence. He kept the autographed ball not as a collectible but for his kids to play with, symbolizing how the shot changed their family's trajectory.
The $1 million was paid out as $50k checks over 20 years. It provided a nice supplement to Calhoun's middle-class lifestyle but did not make him wealthy. The experience and memories were priceless.
Kinda fascinating, it almost surgically removes the entire human interest angle which is the soul of the story that makes it land so strongly. This summary is flat and boring, like a summary of a quarterly SEC filing.
I have a deck of these cards from the 80s in very good condition (except the box is not in good shape). Let me know if you want it and if you live in Seattle I'll give it to you (or I can mail it if you want to pay shipping).
The problem isn't technology but logistics. How are you going to find a large pool of drivers ready to take food instantly from point A to B in the city at little/no cost?
Woops, I guess I was thinking more about ordering online and picking up the food myself. I usually just call the restaurants to place my take out order, but tend to prefer places where I can order on their own app or website, pull up and re-order the last thing I got, and then hit submit. Like someone else mentioned, there is a lot of friction with calling and placing an order, explaining the modifications, paying in the store, etc, etc.
I thought this was such a fabulous idea, I bought a domain name for it: https://inmytown.org/ As usual, I just haven't done all the other hard work. But, in the old days last year, I thought it would be cool for local shops to have an online presence so that online shoppers could see where to buy stuff and place orders and then pick it up. So, have an e-commerce platform for shops, restaurants, delivery would be great. Try and keep money local instead of shaving 10-20% off of all transactions and sending them to big tech. Does anyone want to help me build this? Totally committed to non-profit and great apps for local companies.
I mean, if I'm going to pick up food anyway I'd be happy to pick up someone elses food and drop it off if it was on the way. Presumably someone might do the same for me.
But, about 30 genomic mutations are spontaneous every generation. I have one that causes brittle bone disease. So, just knowing the parents' genomic profile and screening out with IVF will not be sufficient.
In there, they did work on A549 cell lines and showed that removing nutrients from the media decreased their growth rate. They also showed that putting these human cell lines into immune deficient mice and doing a couple 24hr fasts per week had a small (p=0.03) effect on the tumor growth rate (Fig 2). But in the in vivo study, it appears they didn't directly compare A549 vs cisplatin resistant A549 - they seemed to have run 2 studies both vs control.
There are literally thousands of papers showing drugs or treatments which can cure lab mice of "cancer" and many more which can kill cell lines in vivo, but only a tiny percentage of those work in patients. There is a reason this is not in a higher profile journal.
If I am European and I ask Facebook to remove my data, will they also remove pictures of me which are owned by my family? I doubt it, and that's also the problem with providing consent on these DNA databases - they don't require the consent of all of your relatives.
From their blog: "In the US, there is one automotive fatality every 86 million miles across all vehicles from all manufacturers. For Tesla, there is one fatality, including known pedestrian fatalities, every 320 million miles in vehicles equipped with Autopilot hardware. If you are driving a Tesla equipped with Autopilot hardware, you are 3.7 times less likely to be involved in a fatal accident."
Notice it says one fatality per "320 million miles in vehicles equipped with Autopilot hardware." But, how many of those miles (or what percent of the time) does a Tesla driver use Autopilot? Also, maybe those good stats are due to the structural safety features and not the autopilot. It may be more fair to compare to other cars with excellent crash protection but no autopilot.
I think it would be a great service to the world to improve driving safety, but maybe we need to really start looking at the stats and get some more hubris as we transition to full autopilot. For example, require that drivers keep their hands on the wheel and eyes on the road. When more cars have autopilot, then mesh behavior between vehicles, and e-road features, then maybe we'll be more ready for driver-less cars.
> In the US, there is one automotive fatality every 86 million miles across all vehicles from all manufacturers.
Also note that this includes trucks and motorcycles, which have much, much higher fatality rates than passenger cars. Motorcycles are around 10x-50x higher fatality rate than cars! So already Tesla's blog is doing a misleading comparison to more deadly vehicle classes.
Additionally, there could be all sorts of other variables that make it hide even comparison. Are Tesla drivers physically comparable to regular drivers? Are they older? Younger? Both elderly and young kids have a higher accident rates. Are Teslas driven in rural areas and urban areas the same as regular cars? Because rural areas have a higher fatality rate.
So we need to make sure that the Tesla driver matches driving conditions of typical cars to make autopilot comparisons valid.
Right now, it appears Tesla's autopilot is a death-trap.
And don't forget to only compare against 2012+ luxury sedans. The median age of U.S. passenger cars is nearly 12 years. There are exactly 0 autopilot equipped 12 year old cars. As vehicles have become significantly safer in the past 12 years, I wouldn't be surprised if the fatality rate of 2012 and newer luxury sedans was a third of the U.S. median.
> Right now, it appears Tesla's autopilot is a death-trap.
I agree with all the holes you poked in their stats, but then with the last sentence you just went way off the deep end. What does "death trap" mean to you? To me, it seems likely the Autopilot engaged is about as dangerous as disengaged.
Do you find yourself veering dangerously close to a traffic barrier on a regular basis (waiting for the day that the crash attenuator becomes defunct so you can slam into it)? I don't and any machine that does that qualifies as a death trap.
The University of California, Los Angeles, owns a U.S. patent (6,274,119) entitled “Methods for Labeling ß-Amyloid Plaques and Neurofibrillary Tangles”, which has been licensed to TauMark, LLC. Drs. Small, Satyamurthy, Huang, and Barrio are among the inventors and have financial interest in TauMark, LLC. Dr. Small also reports having served as an advisor to and/or having received lecture fees from Allergan, Argentum, Axovant, Cogniciti, Forum Pharmaceuticals, Herbalife, Janssen, Lundbeck, Lilly, Novartis, Otsuka, and Pfizer. Dr. Heber reports receiving consulting fees from Herbalife, and the McCormick Science Institute. The manufacturer of Theracurmin, Theravalues Corporation, provided the Theracurmin and placebo for the trial, funds for laboratory testing of blood curcumin levels, and funds for Dr. Small's travel to the 2017 Alzheimer's Association International Conference for presentation of the findings.
https://shademap.app/@40.75481,-73.98696,14.82042z,171702794...
https://www.amnh.org/research/hayden-planetarium/manhattanhe...